ArticleRheumatology (Oxford, England)2026
Cardiovascular and thromboembolic risk in ANCA-associated vasculitis: a nationwide matched cohort study by disease, sex and familial risk.
Article in Rheumatology (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectivesTo investigate influence of sex, diagnosis (granulomatosis with polyangiitis (GPA) vs microscopic polyangiitis (MPA)) and familial factors on cardiovascular disease and thromboembolism (CVD-TE) risk in patients with ANCA-associated vasculitis (AAV).
methodsAdults with a diagnosis of GPA or MPA were identified from National Patient Registers (2005-2020) with five age- and sex-matched population controls randomly selected per patient. First-degree siblings of patients and matched controls were included. Outcomes were defined using ICD codes and included myocardial infarction (MI), ischaemic or haemorrhagic stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), CVD-TE-related death and a composite CVD-TE end point. Hazard ratios (HRs) with 95% CIs were estimated using Cox proportional hazards models.
resultsA total of 4317 AAV patients, 21 582 controls and 25 568 siblings were included. Both GPA and MPA were associated with increased CVD-TE risk compared with the controls (HR 2.04 [1.83, 2.38] and HR 2.45 [2.00, 2.99]), with no differences between GPA and MPA for individual outcomes. Both sexes had increased DVT and PE risks. In GPA, only males had increased MI risk (HR 2.25 [1.74, 2.92]), whereas only females had increased ischaemic stroke risk (HR 1.64 [1.25, 2.17]). Siblings of AAV patients had no excess CVD-TE risk. The highest CVD-TE risk occurred within 3 months of diagnosis (HR 7.69 [5.93, 9.99]).
conclusionGPA and MPA were associated with comparable increased risks of CVD-TE, with the highest risk within 3 months following AAV diagnosis and with sex-specific differences in GPA. Lack of increased risk among siblings emphasize the vasculitis per se as a risk factor for CVD-TE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.